Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Lately, Pfizer (NYSE: PFE) ...

Two drugs. Two strategies. One industry in the middle of a rewiring.

President Donald Trump's tariff-induced stock swoon rolled out the red carpet for investors to snag high-quality stocks at a ...

Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...

The global sales for Endometriosis Treatment as anticipated for 2025 was to be valued at USD 3.73 billion and by 2035 was projected to amount to USD 6.30 billion. Such sales would consider a CAGR ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Treatment Market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million. As ...

Atherosclerosis Market Atherosclerosis Market Forecasted to Expand from USD 47.6 Billion in 2025 to USD 62.2 Billion by 2035 From m ...

Dr. Dinarello has trained over 50 medical investigators, many of whom are recognized as experts in their fields of medicine. The Institute for Science Information has listed Dr. Dinarello as the world ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...